Why the study?
What are the determinants and impact of heart failure readmission following transcatheter aortic valve replacement?
What are the determinants and impact of heart failure readmission following transcatheter aortic valve replacement?
Baseline comorbidities and discharge echocardiographic findings can identify patients at high risk for heart failure readmission after TAVR, which is associated with increased long-term mortality.
HF readmissions after TAVR associate with higher mortality; supports comorbidity- and echo-based risk stratification but leaves open causal interventions.
HF readmission is common within 1-year of TAVR. Late and multiple HF readmissions associate with an increased risk of long-term all-cause mortality. Baseline comorbidities (diabetes, chronic lung disease, previous acute HF) and echocardiographic findings at discharge (grade III or IV aortic regurgitation, pulmonary hypertension) identified patients at high risk of HF readmission.
No takes yet. Share an insight, caveat, or question.
Auffret et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: